WallStreetZenWallStreetZen

NASDAQ: INO
Inovio Pharmaceuticals Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

INO past revenue growth

How has INO's revenue growth performed historically?
Company
-91.89%
Industry
145.22%
Market
17.76%
INO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
INO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
INO's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

INO earnings and revenue history

Current Revenue
$832.0k
Current Earnings
-$135.1M
Current Profit Margin
-16,239.9%

INO Return on Equity

Current Company
-86.6%
Current Industry
-63.5%
Current Market
188%
INO's Return on Equity (-86.6%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when INO announces earnings.

INO Return on Assets

Current Company
-62.6%
Current Industry
2.9%
INO is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

INO Return on Capital Employed

Current Company
-104.29%
Current Industry
19.5%
INO's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

INO vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
INO$832.01k-$130.39M-$135.12M-51.33%N/A
CDXC$83.57M-$3.23M-$4.94M+21.50%N/A
NKTR$90.12M-$243.11M-$276.06M-40.35%N/A
AGEN$156.31M-$134.25M-$245.97M+33.56%N/A
EPIX$0.00-$25.69M-$25.80MN/AN/A
View Top Biotech Stocks

INO earnings dates

Next earnings date
May 21, 2024

Inovio Pharmaceuticals Earnings & Revenue FAQ

What were INO's earnings last quarter?

On Invalid Date, Inovio Pharmaceuticals (NASDAQ: INO) reported Q4 2023 earnings per share (EPS) of -$1.05, up 58.82% year over year. Total Inovio Pharmaceuticals earnings for the quarter were -$25.00 million. In the same quarter last year, Inovio Pharmaceuticals's earnings per share (EPS) was -$2.55.

If you're new to stock investing, here's how to buy Inovio Pharmaceuticals stock.

What was INO's earnings growth in the past year?

As of Q2 2024, Inovio Pharmaceuticals's earnings has grown year over year. Inovio Pharmaceuticals's earnings in the past year totalled -$135.12 million.

What is INO's earnings date?

Inovio Pharmaceuticals's earnings date is Invalid Date. Add INO to your watchlist to be reminded of INO's next earnings announcement.

What was INO's revenue last quarter?

On Invalid Date, Inovio Pharmaceuticals (NASDAQ: INO) reported Q4 2023 revenue of $102.65 thousand up 17.66% year over year. In the same quarter last year, Inovio Pharmaceuticals's revenue was $124.67 thousand.

What was INO's revenue growth in the past year?

As of Q2 2024, Inovio Pharmaceuticals's revenue has grown -91.89% year over year. This is 237.12 percentage points lower than the US Biotechnology industry revenue growth rate of 145.22%. Inovio Pharmaceuticals's revenue in the past year totalled $832.01 thousand.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.